Editorial Board

Editorial Board

Simon Maxwell (Co-Director)

University of Edinburgh (UK)

Simon Maxwell is Professor of Student Learning/Clinical Pharmacology and Director of Clinical Pharmacology & Therapeutics teaching at the University of Edinburgh, where he has been active in developing e-Learning strategies to support education in this area. His clinical responsibilities include supervision of acute medical admissions and the management of outpatients at increased cardiovascular risk. He was lead author of the core curriculum for CPT teaching in UK medical schools. He is Chair of the European Association of CPT (EACPT) Education Committee and Secretary of the International Union of Pharmacology and Clinical Pharmacology (IUPHAR) Education Section. He was formerly Vice-President of the BPS and is a fellow of the Royal Colleges of Physicians in London and Edinburgh and of the Higher Education Academy. He is Clinical lead for the Prescribe project, a joint collaboration between the Department of Health, Medical Schools Council (MSC) and BPS to deliver a national eLearning solution to develop safe and effective prescribing amongst UK medical students. He is Medical Director of the Prescribing Safety Assessment, a joint initiative by the BPS and MSC to produce a national assessment of prescribing for all UK medical students.

John Szarek (Co-Director)

Geisinger Commonwealth School of Medicine in Scranton (US)

Dr. John Szarek is Professor of Pharmacology in the Department of Basic Sciences and Director of Clinical Pharmacology at the Geisinger Commonwealth School of Medicine in Scranton PA. He also is Education Director for Simulation at Geisinger Commonwealth, a Certified Healthcare Simulation Educator and co-leader for the Interprofessional Education curriculum thread. Dr. Szarek received his Ph.D. in Pharmaceutical Sciences from the University of Kentucky College of Pharmacy, a B.S. in Pharmacy from the University of Illinois Chicago College of Pharmacy, and a B.S. in Biology from the University of Illinois Urbana. He has held professorships and professorships with administrative positions at Marshall University (Joan C Edwards) School of Medicine, Chair and Director of the Simulation PBL Program at Ross University School of Medicine, and Director of Human Simulation at A.T. Still University School of Osteopathic Medicine in Arizona. Dr. Szarek has participated in many workshops on teaching and learning including two sponsored by the Harvard Macy Institute. His interests focus on the use of technology in medical education. 

Elizabeth Davis

Monash University (Australia)

Elizabeth Davis is an Education-Focused Senior Lecturer in the Department of Pharmacology within the Faculty of Medicine, Nursing & Health Sciences at Monash University. She promotes the discipline of pharmacology both nationally and internationally by her work for ASCEPT and IUPHAR where she is Secretary of its Education Section (IUPHAR-Ed). She is also helping to promote quality of teaching of pharmacology across all relevant degree programs at Monash University where she has particular interests in fostering better student engagement with their studies and the use of technology in teaching and learning.

    Fenghua Fu

    Yantai University (China)

    Dr. Fenghua Fu is Professor of Pharmacology and Dean of the Pharmacy School at Yantai University. He is also a member of the Committee of the Chinese Pharmacological Society (CNPHARS), the Director of the National Demonstration Center for Experimental Pharmaceutical Education (Yantai University), and the Director of Key Laboratory of Molecular Pharmacology and Drug Evaluation (Ministry of Education of China). Dr. Fu is active in teaching pharmacology for undergraduates and molecular pharmacology for postgraduates. He has been awarded the national outstanding teacher title by the Ministry of Education for his excellence teaching. Dr. Fu received his Ph.D. in basic pharmacology from Shandong University Medical School. His research interests focus on neuro-psychopharmacology and on new drug evaluation.

    Kuniaki Ishii

    Yamagata University School of Medicine (Japan)

    Dr. Kuniaki Ishii received his M.D. degree from Tohoku University School of Medicine (Japan) in 1981; and Ph.D. degree from Tohoku University Graduate School of Medicine (Japan) in 1986. He completed his postdoctoral training at Stanford University (Department of Medicine and Pharmacology, 1986-1988). He was appointed as research associate at Department of Pharmacology, Tohoku University School of Medicine (Japan) in 1986. He was then promoted to assistant professor at Department of Neurophysiology, Tohoku University School of Medicine in 1995, and to associate professor at Department of Cardiovascular Pharmacology, Yamagata University School of Medicine (Japan) in 1997. Since 2006, he has been a full professor at Department of Pharmacology, Yamagata University School of Medicine.

    Dr. Ishii is currently a member of the Board of Directors of the Japanese Pharmacological Society (JPS) and an Auditor of Japanese Association of Cardiovascular Pharmacology. He has been serving as the Editorial Board Member of Pharmacology since 2012.

    Dr. Ishii started his research career in cardiac pharmacology studying the effects of Ca2+ channel antagonists on cardiac muscles. He, then, gradually got interested in ion channels. In order to pursue molecular biological studies, he spent two years in the laboratory of Prof. Ferid Murad (just before the Nobel Prize in 1988) at Stanford University, where he worked on the cloning of soluble guanylyl cyclase. After returning to Japan, he studied at Dr. Shigetada Nakanishi's lab at Kyoto University (Japan) for a year to learn expression cloning technique that was developed by Dr. Nakanishi. He then set up a molecular biology laboratory in Tohoku University. His current research interests center on molecular pharmacology of potassium channels in conjunction with cardiovascular functions. He has identified several potassium channels from the mammalian heart and studied their structure-function relationships and pharmacological modulation.

    Kelly Karpa

    Pennsylvania State University (US)

    Dr. Kelly Karpa is a pharmacist and a pharmacologist.  She has been director of Medical Pharmacology Instruction at Pennsylvania State University College of Medicine since 2008 and is co-director of the Office for Inter-professional Collaborative Education and Teamwork at the medical school. Dr. Karpa has authored a book about dietary supplements entitled Bacteria for Breakfast: Probiotics for Good Health and is co-author of two editions of the pharmacology textbook Elsevier’s Integrated Pharmacology. She is a Josiah Macy Faculty Scholar who is developing inter-professional clinical pharmacology curricula and has a passion for helping students transition between having only “head” knowledge of drug facts to application of pharmacologic principles to maximize safe and effective use of medications when caring for patients. 

    John Peters

    University of Dundee (UK)

    John Peters is Professor of Pharmacology at the University of Dundee. He is currently active in the teaching of Pharmacology and Physiology to undergraduate students of Medicine, Dentistry and Biomedical Sciences, in addition to contributing to post-graduate medical teaching in Neuropharmacology (Psychiatry). He received his B.Sc. in Neurobiology from the University of Sussex and Ph.D in Zoology (specialising in Neuropharmacology) from the University of Nottingham. At the University of Dundee he has served as Degree Convenor for B.Sc. degrees in Pharmacology and Neuroscience and as Associate Dean for Biomedical Science Education. He is a co-editor of the NC-IUPHAR/British Journal of Pharmacology (BJP) Guide to Pharmacology and has acted in a similar role in its predecessors published by Trends in Pharmacology Sciences (TiPS) and the BJP. He is currently a member of the Committee of NC-IUPHAR. His research interests have focused upon molecular and cellular aspects of the operation and function of transmitter-gated ion channels of the Cys-loop family. He is a joint recipient of the Novartis (formerly Sandoz) and Rang Prizes of the British Pharmacological Society (BPS). At the University of Dundee, he has been awarded Prizes for ‘Excellence in Teaching and Supporting Learning’ and for ‘Continuing Excellence in Medical Education’ and in a pastoral role as student nominated ‘Best Student Advisor (2013)’.

    Chay-Hoon Tan

    National University of Singapore (Singapore)

    Dr Tan is an Associate Professor in Pharmacology, National University of Singapore (NUS) and Consultant Psychiatrist, National University Hospital. She served on the Curriculum Review, Problem Based Learning, Educational Task Force of Yong Loo Lin School of Medicine, as well as the Committee for Professional Development of Communication. She coordinated the Mentoring Program. She is also an associate of Medical Education Unit, NUS and is actively involved in faculty development.  She coordinates research in the use of psychotropic drugs in Asia countries. Dr Tan is also working on pharmaco-genetic and research model of psychiatric disorders in addition to the biomarkers of pathological ageing. She serves on the editorial board of Medical Progress and International Journal of Mental Health and helps reviewing manuscripts for various International Neuroscience and Psychiatric Journals. Dr Tan is active in undergraduate and postgraduate teaching and assessments. Dr Tan has received multiple teaching awards from the University. 

     

    Leszek Wojnowski

    Mainz University Medical Center (Germany)

    Leszek Wojnowski is Professor of Clinical Pharmacology and Pharmacogenetics at the University Medical Center in Mainz, Germany. His research focuses on the determinants of the inter-individual differences in response to drugs. Since 2008 Professor Wojnowski has been working to improve pharmacology teaching at KCMUCO, beginning with lectures and lecture recordings. In 2012 he began delivering pharmacology teaching materials including video lectures and self-assessment materials via the learning curriculum management system provided by Duke University within the the US NIH-sponsored Medical Education Partnership Initiative.